Celularity (CELU) FCF Margin Growth (1y) (2021 - 2025)
Celularity (CELU) FCF Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 769.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 19,111.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 811.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 4,109.00 |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | -14,818.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,614.00 |
| Sep 30, 2025 | -7,731.00 |
| Jun 30, 2025 | 1,131.00 |
| Mar 31, 2025 | 406.00 |
| Dec 31, 2024 | 6,243.00 |
| Sep 30, 2024 | 20,410.00 |
| Jun 30, 2024 | 37,386.00 |
| Mar 31, 2024 | 35,612.00 |
| Dec 31, 2023 | 58,449.00 |
| Sep 30, 2023 | 74,452.00 |
| Jun 30, 2023 | 60,899.00 |
| Mar 31, 2023 | 20,786.00 |
| Dec 31, 2022 | -2,555.00 |
| Sep 30, 2022 | -58,832.00 |
| Jun 30, 2022 | -44,338.00 |
| Mar 31, 2022 | 35,941.00 |
| Dec 31, 2021 | 20,842.00 |
| Sep 30, 2021 | 99,711.00 |